Picture of Seegnal logo

SEGN Seegnal Share Price

0.000.00%
ca flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+235.53%
3m+218.23%
6m+202.62%
1yr+185.44%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value336.33
Price to Tang. Book336.33
Price to Free Cashflown/a
Price to Salesn/a
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-129.28%
Return on Equity-76.01%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Aug 202531st Aug 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Seegnal EPS forecast chart

Profile Summary

Seegnal Inc., through its wholly owned subsidiary Seegnal eHealth Ltd. (Seegnal eHealth), is engaged in solving the causes of death and injuries in the modern world - Adverse Drug Effects (ADEs). Its Clinical Decision Support system introduces a paradigm shift in the approach to this problem by implementing a new elevated Patient-Centric Standard. Its SaaS technology integrates at the point-of-care, patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age, and the effects of many concomitant medications, while reducing the alert load for clinicians by over 90%, by removing irrelevant alerts. Its eHealth is marketing its SaaS-based platform in the State of Israel, the UAE, the United Kingdom, the United States, and Poland. The platform is a standard of care system for over 10,000 clinicians in Israel, used on a daily basis for prescribing medications to their patients.

Directors

    Last Annual
    August 31st, 2024
    Last Interim
    May 31st, 2025
    Incorporated
    August 21st, 2025
    Public Since
    February 11th, 2022
    Sector
    Software & IT Services
    Industry
    Technology
    Exchange
    ca flag iconTSX Venture Exchange
    Shares in Issue
    45,319,031
    Blurred out image of a map
    Address
    1900 - 520 - 3rd Avenue SW, CALGARY, T2P 0R3
    Web
    Phone
    Auditors
    SRCO Professional Corporation

    SEGN Share Price Performance

    Similar to SEGN

    Picture of 01 Quantum logo

    01 Quantum

    ca flag iconTSX Venture Exchange

    Picture of Acceleware logo

    Acceleware

    ca flag iconTSX Venture Exchange

    Picture of AGEDB Technology logo

    AGEDB Technology

    ca flag iconTSX Venture Exchange

    Picture of Agereh Technologies logo

    Agereh Technologies

    ca flag iconTSX Venture Exchange

    Picture of Aisix Solutions logo

    Aisix Solutions

    ca flag iconTSX Venture Exchange

    FAQ